ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

VTVT vTv Therapeutics Inc

23,63
-0,0699 (-0,29%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
vTv Therapeutics Inc VTVT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0699 -0,29% 23,63 06:00:09
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
22,85 22,5001 24,33 23,63 23,6999
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
19.3.202413:30PRNUSCANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA..
13.3.202413:00GLOBEvTv Therapeutics Announces 2023 Fourth Quarter and Full Year..
07.3.202422:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
06.3.202401:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
05.3.202414:04EDGAR2Form 8-K - Current report
04.3.202414:00GLOBEvTv Therapeutics Announces FDA Submission for First Phase 3..
01.3.202414:00GLOBEvTv Therapeutics to Participate at the TD Cowen 44th Annual..
28.2.202415:26EDGAR2Form 8-K - Current report
28.2.202415:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.2.202414:08EDGAR2Form 8-K - Current report
28.2.202414:00GLOBEvTv Therapeutics Announces $51 Million Private Placement..
22.2.202422:00PRNUSCANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO &..
22.12.202322:26EDGAR2Form 8-K - Current report
19.12.202322:28EDGAR2Form 8-K - Current report
12.12.202322:21EDGAR2Form 8-K - Current report
20.11.202322:23EDGAR2Form 8-K - Current report
15.11.202314:22EDGAR2Form 8-K - Current report
15.11.202314:19EDGAR2Form 8-K - Current report
09.11.202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:30GLOBEvTv Therapeutics Announces 2023 Third Quarter Financial..
09.11.202322:20EDGAR2Form 8-K - Current report
08.11.202314:00GLOBEvTv Therapeutics to Participate at the Stifel 2023..
02.11.202313:00GLOBEvTv Therapeutics Appoints Thomas Strack, M.D., as Chief..
01.11.202313:24EDGAR2Form 8-K - Current report
01.11.202313:00GLOBEvTv Therapeutics Announces Sale of Shares in Reneo..
27.9.202314:30PRNUSCANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A..
26.9.202314:30PRNUSCantex and Allegheny Health Network Announce Initiation of a..
25.9.202322:20EDGAR2Form DEF 14C - Other definitive information statements
18.9.202314:30PRNUSCANTEX PHARMACEUTICALS AND LENOX HILL HOSPITAL ANNOUNCE..
15.9.202322:17EDGAR2Form PRE 14C - Other preliminary information statements
11.8.202322:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202322:36EDGAR2Form 8-K - Current report
11.8.202322:30GLOBEvTv Therapeutics Announces 2023 Second Quarter Financial..
10.8.202314:33PRNUSCantex Pharmaceuticals Announces Article Published in npj..
20.7.202322:22EDGAR2Form 8-K - Current report
16.6.202314:00GLOBEvTv Therapeutics Partner Cantex Pharmaceuticals Licenses..
15.6.202313:33PRNUSCANTEX PHARMACEUTICALS TO PRESENT AT THE MEDINVEST ONCOLOGY..
24.5.202315:00GLOBEvTv Therapeutics Announces Issuance of U.S. Patent for..
11.5.202322:15GLOBEvTv Therapeutics Announces 2023 First Quarter Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock